Multiomic analysis of immune-related adverse events (irAEs) in melanoma patients treated with anti-PD1-based immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
Dimitriou, F.
Cheng, P. [1 ]
Saltari, A. [1 ]
Staeger, R. [1 ]
Tastanova, A. [1 ]
Levesque, M. [1 ]
Long, G. [3 ]
Becher, B. [2 ]
Dummer, R. [1 ]
机构：
[1] Univ Spital Zurich, Dept Dermatol, Zurich, Switzerland
[2] Univ Zurich, Dept Immunol, Zurich, Switzerland
[3] Melanoma Inst Australia, Sydney, NSW, Australia
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
1607
引用
收藏
页码：S275 / S275
页数：1
相关论文
共 50 条
  • [1] Frequency of delayed immune-related adverse events (irAEs) in hospitalized patients treated with immune checkpoint inhibitors (ICIs)
    Durbin, Sienna
    Zubiri, Leyre
    Perlman, Katherine
    Molina, Gabriel
    Jacoby, Ted
    Shah, Nishi
    Reynolds, Kerry Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Delayed immune-related adverse events (irAEs) on anti-PD1-based therapy
    Owen, C. N.
    Bai, X.
    Quah, T.
    Lo, S.
    Callaghan, S.
    Martinez-Vila, C.
    Bhave, P.
    Reijers, I.
    Gerard, C. L.
    Aspelagh, S.
    Xu, W.
    Welsh, S. J.
    Sandhu, S.
    Mangana, J.
    McQuade, J. L.
    Ascierto, P. A.
    Zimmer, L.
    Johnson, D. B.
    Lebbe, C.
    Menzies, A. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S761 - S762
  • [3] Patterns of immune-related adverse events (irAEs) in adolescent and young adult (AYA) patients with melanoma receiving immune checkpoint inhibitors (ICIs)
    He, Jiasen
    John, Ida
    Afridi, Faraz
    Sun, Mianen
    Wang, Yinghong
    Roth, Michael
    McQuade, Jennifer Leigh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [5] Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
    Riudavets Melia, M.
    Gabriela Sullivan, I.
    Barba Joaquin, A.
    Anguera Palacios, G.
    del Carpio, L. P.
    Molto Valiente, C.
    Camacho Arellano, S. D.
    Moron Asensio, S.
    Gomila Pons, P.
    Andres Granyo, M.
    Castillo Villegas, D.
    Facundo Molas, C.
    Garcia Planella, E.
    Gonzalez Blanco, C.
    Barnadas Molins, A.
    Gich Saladich, I.
    Majem Tarruella, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 509 - 509
  • [6] Immune checkpoint inhibitors (ICIs) in gastrointestinal (GI) cancer: Immune-related adverse events (IRAEs) and efficacy.
    Das, Satya
    Ciombor, Kristen Keon
    Haraldsdottir, Sigurdis
    Pumpalova, Yoanna S.
    Sahin, Ibrahim Halil
    Shyr, Yu
    Chu, Shih-Kai
    Lin, Emily Pei-Ying
    Hsu, Chih-Yuan
    Goff, Laura Williams
    Cardin, Dana Backlund
    Bilen, Mehmet Asim
    Berlin, Jordan
    Wu, Christina
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Immune-related adverse events (irAEs) and survival in solid tumors treated with immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis.
    Grizzi, Giulia
    Petrelli, Fausto
    Ghidini, Michele
    Ghidini, Antonio
    Ratti, Margherita
    Panni, Stefano
    Cabiddu, Mary
    Ghilardi, Mara
    Borgonovo, Karen
    Parati, Maria Chiara
    Barni, Sandro
    Tomasello, Gianluca
    Passalacqua, Rodolfo
    Berruti, Alfredo
    Brighenti, Matteo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients
    Giommoni, Elisa
    Giorgione, Roberta
    Paderi, Agnese
    Pellegrini, Elisa
    Gambale, Elisabetta
    Marini, Andrea
    Antonuzzo, Andrea
    Marconcini, Riccardo
    Roviello, Giandomenico
    Matucci-Cerinic, Marco
    Capaccioli, David
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    IMMUNO, 2021, 1 (03): : 253 - 263
  • [9] Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors
    Ornstein, Moshe C.
    Calabrese, Cassandra
    Wood, Laura S.
    Kirchner, Elizabeth
    Profusek, Pamela
    Allman, Kimberly D.
    Martin, Allison
    Kontzias, Arstolos
    Grivas, Petros
    Garcia, Jorge A.
    Calabrese, Leonard H.
    Rini, Brian, I
    CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : 177 - 182
  • [10] Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors
    Gault, A.
    Anderson, A. E.
    Plummer, R.
    Stewart, C.
    Pratt, A. G.
    Rajan, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (02) : 263 - 271
12345